Shengping HOU | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Prof. Shengping HOU | Medicine and Dentistry | Best Researcher Award

Director of Beijing Institute of Ophthalmology at Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, China

Dr. Shengping Hou is a prominent figure in ophthalmology, currently serving as a Professor and Director at the Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Capital Medical University. With extensive experience in ocular immunology and stem cell biology, he has contributed significantly to advancing research in vision science. His leadership roles and numerous research grants highlight his dedication to developing innovative solutions for ocular diseases. Dr. Hou has delivered invited lectures at international conferences and is actively engaged in professional service, serving as an ad hoc reviewer for esteemed journals. His work has earned him several prestigious awards, including national recognition for his achievements in science and technology.

Professional Profile

Education

Dr. Hou earned his Ph.D. in Ocular Immunology from Sun Yat-sen University, China, in 2009, showcasing his foundation in understanding immune-related ocular diseases. He further honed his expertise as a postdoctoral fellow in Ocular Stem Cell Biology at the University of California, San Francisco, in 2016. This educational background has equipped him with cutting-edge knowledge and skills, enabling him to explore and address complex issues in ophthalmology.

Professional Experience

Dr. Hou began his career as an Associate Professor at Chongqing Medical University (2009–2015), where he played a key role in ophthalmology research at the Chongqing Key Laboratory of Ophthalmology. In 2015, he was promoted to Professor, continuing his impactful work at the same institution until 2023. Currently, Dr. Hou serves as the Director at the Beijing Institute of Ophthalmology, where he leads advanced research initiatives and oversees clinical operations.

Research Interests

Dr. Hou’s research interests focus on ocular immunology, ocular stem cell biology, and the genetic basis of ocular diseases. His work delves into understanding the molecular and genetic mechanisms underlying conditions such as VKH syndrome and Behçet’s disease, with the aim of developing innovative treatments. His commitment to translating basic research into clinical solutions highlights his dedication to improving patient outcomes in ophthalmology.

Research Skills

Dr. Hou possesses advanced expertise in genetic and molecular studies, including gene editing and analysis of copy number variants. His skills also encompass stem cell culture techniques, immunological assays, and bioinformatics tools for studying ocular diseases. Additionally, his experience in securing and leading research grants demonstrates his strategic planning and leadership abilities in scientific endeavors.

Awards and Honors

Dr. Hou has received numerous awards for his contributions to ophthalmology and scientific research. These include the First Prize for the Achievement in Science and Technology from Chongqing (2010, 2015) and the Chinese Health Ministry (2012). In 2018, he was awarded the Second Prize for Scientific and Technological Progress of China, reflecting the national recognition of his impactful work. His accolades underscore his commitment to advancing knowledge in vision science and his leadership in the field.

Conclusion

Dr. Shengping Hou is a highly accomplished researcher with significant contributions to ocular immunology and stem cell biology. His academic leadership, research funding success, and national awards make him a strong candidate for the Best Researcher Award. However, further emphasis on international collaboration, impactful publications, and translational innovations could make his candidature even more competitive. Overall, Dr. Hou’s accomplishments and leadership in ophthalmology research align well with the criteria for this prestigious award.

Publication Top Notes

  1. Ocular immune-related diseases: molecular mechanisms and therapy”
    • Authors: Wang, Y.; Gao, S.; Cao, F.; Lei, F.; Hou, S.
    • Year: 2024
  2. “m6A-methylase METTL3 promotes retinal angiogenesis through modulation of metabolic reprogramming in RPE cells”
    • Authors: Zhou, Q.; Liu, X.; Lu, H.; Yang, P.; Hou, S.
    • Year: 2024
  3. “A novel metric of autoimmune disease burden and its estimated incidence across different stages in the life cycle of women”
    • Authors: Cao, F.; Pan, H.-F.; Hou, S.
    • Year: 2024
  4. “A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis”
    • Authors: Fan, W.; Zeng, S.; Wang, X.; Li, N.; Hou, S.
    • Year: 2024
    • Citations: 3
  5. “Transcription factor EGR2 alleviates autoimmune uveitis via activation of GDF15 to modulate the retinal microglial phenotype”
    • Authors: Li, W.; He, S.; Tan, J.; Yang, P.; Hou, S.
    • Year: 2024
    • Citations: 2
  6. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X.; Wang, G.; Li, N.; Zhou, Q.; Hou, S.
    • Year: 2024
    • Citations: 1
  7. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X.; Zhou, Q.; Meng, J.; Mao, L.; Hou, S.
    • Year: 2024
    • Citations: 1
  8. “Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis”
    • Authors: Cao, F.; Liang, K.; Tang, W.-W.; Tao, L.-M.; Wang, X.
    • Year: 2024
    • Citations: 6
  9. “Trends and cross-country inequalities in the global burden of osteoarthritis, 1990–2019: A population-based study”
    • Authors: Cao, F.; Xu, Z.; Li, X.-X.; Hou, S.; Pan, H.-F.
    • Year: 2024
    • Citations: 14
  10. “YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes”
    • Authors: Huang, J.; Wang, X.; Li, N.; Yang, P.; Hou, S.
    • Year: 2024
    • Citations: 9

 

Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Ph.D. Student at Taipei Medical University, Taiwan.

Bao Tu Thai Nguyen is a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, Taiwan, under the supervision of Assistant Professor Yu-Pin Chen. He also serves as a lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy, Vietnam, and as an attending physician in the Department of Orthopedics and Neurosurgery at the university’s hospital. Bao Tu holds a Bachelor of Medicine and has contributed extensively to orthopedic research, with publications in esteemed journals like World Neurosurgery and EFORT Open Reviews. His work includes meta-analyses on topics such as anterior cervical discectomy, hip fracture mortality, and the impact of smoking on surgical outcomes. Bao Tu has presented at international conferences, including the European Federation of National Societies of Orthopaedics and Traumatology and the Japanese Orthopaedic Association. His research focuses on orthopedic surgery outcomes, biometrics, and predictive modeling in clinical settings.

Profile:

Education

Bao Tu Thai Nguyen is currently pursuing a Ph.D. in Medicine at the International Graduate Program in Medicine, Taipei Medical University, Taiwan, under the guidance of Assistant Professor Yu-Pin Chen. He began his doctoral studies in September 2022, focusing on advancing his expertise in the field of orthopedic surgery and neurosurgery. Prior to his Ph.D., Nguyen earned his Bachelor of Medicine from Can Tho University of Medicine and Pharmacy, Vietnam, where he completed his studies between September 2013 and July 2019. His strong foundation in medical education has equipped him with extensive clinical knowledge, particularly in orthopedics. Throughout his academic journey, Nguyen has demonstrated a deep commitment to research and medical practice, contributing to multiple peer-reviewed publications and international presentations. His ongoing doctoral research aims to further enhance his skills and make meaningful contributions to the field of orthopedic medicine and surgery.

Professional Experience

Bao Tu Thai Nguyen is a Ph.D. student at Taipei Medical University, specializing in orthopedic research. Since June 2020, he has served as a Lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy in Vietnam, where he shares his expertise in orthopedic surgery with medical students. In addition, since December 2020, he has been an Attending Physician in the Department of Orthopedics and Neurosurgery at Can Tho University of Medicine and Pharmacy Hospital. In this role, he provides patient care, performs surgeries, and collaborates with other healthcare professionals to deliver high-quality treatment in orthopedic and neurosurgical cases. His work spans teaching, clinical practice, and research, where he has co-authored multiple peer-reviewed publications on topics such as spinal surgery, joint reconstruction, and trauma management. His dual roles as an academic and practicing physician underscore his dedication to advancing orthopedic healthcare in Vietnam.

Research Interest

Bao Tu Thai Nguyen, a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, focuses his research on orthopedics, with a particular interest in spine surgery, joint reconstruction, and trauma care. His work emphasizes evidence-based approaches, with extensive contributions to meta-analyses on the effectiveness of surgical techniques, such as anterior cervical discectomy and fusion, and the impact of patient factors like smoking on surgical outcomes. Nguyen’s research also delves into innovative treatment methods for fractures and the use of advanced biomaterials in orthopedic surgery, including Polyetheretherketone (PEEK) implants. Additionally, he investigates predictive modeling in orthopedics, such as predicting hamstring graft size for ligament reconstruction based on anthropometric measurements. His commitment to improving surgical outcomes and patient care is evident through his prolific publications and active participation in international conferences, positioning him as a promising researcher in orthopedic and trauma surgery.

Research Skills

Bao Tu Thai Nguyen is a highly skilled researcher with a strong background in orthopedic and neurosurgery research. Currently pursuing a Ph.D. at Taipei Medical University, he has demonstrated expertise in conducting meta-analyses and systematic reviews, as evidenced by his numerous publications in international journals. His research focuses on surgical techniques, implant materials, and risk factors in orthopedic surgery, particularly in spine and fracture management. Bao Tu’s work includes comparative studies of structural allografts versus synthetic materials in surgeries such as anterior cervical discectomy and fusion. He is also proficient in analyzing the impact of lifestyle factors like smoking on surgical outcomes. His proficiency in data analysis, medical statistics, and clinical research methodology has led to several international presentations. Bao Tu’s collaboration with leading academics in Taiwan and Vietnam further highlights his research capabilities, making him a well-rounded and impactful researcher in his field.

Award and Recognition

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Conclusion

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Publication Top Notes

  1. The Association between Red Blood Cell Distribution Width and Mortality Risk after Hip Fracture: A Meta-Analysis
    • Authors: Nguyen, B.T.T.; Tran, D.N.A.; Nguyen, T.T.; Kuo, Y.-J.; Chen, Y.-P.
    • Year: 2024
    • Journal: Medicina (Lithuania)
    • Volume/Issue: 60(3), 485
    • Citations: 3
  2. Adverse Effect of Smoking on Surgical Site Infection following Ankle and Calcaneal Fracture Fixation: A Meta-Analysis
    • Authors: Tran, D.N.A.; Nguyen, B.T.T.; Nguyen, T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: EFORT Open Reviews
    • Volume/Issue: 9(8), pp. 817–826
  3. Is Smoking a Risk Factor for Complications Following Total Ankle Arthroplasty? A Meta-Analysis
    • Authors: Le, Y.T.T.; Tran, D.N.A.; Nguyen, B.T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: Foot and Ankle Surgery (Article in Press)
  4. Two-port Endoscopic Surgery for Carpal Tunnel Syndrome – A Prospective Cohort Study
    • Authors: Nguyen, T.T.; Duong, K.; Tran, S.Q.; Ly, H.H.V.; Nguyen, B.T.T.
    • Year: 2022
    • Journal: Malaysian Orthopaedic Journal
    • Volume/Issue: 16(2), pp. 55–62
    • Citations: 2

 

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79